59 related articles for article (PubMed ID: 11391544)
1. Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens.
Urbani S; Uggeri J; Matsuura Y; Miyamura T; Penna A; Boni C; Ferrari C
Hepatology; 2001 Jun; 33(6):1533-43. PubMed ID: 11391544
[TBL] [Abstract][Full Text] [Related]
2. Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV.
Wong DK; Dudley DD; Dohrenwend PB; Lauer GM; Chung RT; Thomas DL; Walker BD
J Virol; 2001 Feb; 75(3):1229-35. PubMed ID: 11152496
[TBL] [Abstract][Full Text] [Related]
3. Identification of the epitopes on HCV core protein recognized by HLA-A2 restricted cytotoxic T lymphocytes.
Zhou HC; Xu DZ; Wang XP; Zhang JX; Huang Y; Yan YP; Zhu Y; Jin BQ
World J Gastroenterol; 2001 Aug; 7(4):583-6. PubMed ID: 11819836
[TBL] [Abstract][Full Text] [Related]
4. Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens.
Agrawal B; Gupta N; Vedi S; Singh S; Li W; Garg S; Li J; Kumar R
Cells; 2019 May; 8(5):. PubMed ID: 31130710
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model.
Arichi T; Saito T; Major ME; Belyakov IM; Shirai M; Engelhard VH; Feinstone SM; Berzofsky JA
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):297-302. PubMed ID: 10618412
[TBL] [Abstract][Full Text] [Related]
6. Functional measurement of hepatitis C virus core-specific CD8(+) T-cell responses in the livers or peripheral blood of patients by using autologous peripheral blood mononuclear cells as targets or stimulators.
Fang SH; Chiang BL; Wu MH; Iba H; Lai MY; Yang PM; Chen DS; Hwang LH
J Clin Microbiol; 2001 Nov; 39(11):3895-901. PubMed ID: 11682504
[TBL] [Abstract][Full Text] [Related]
7. Immunodominance of HLA-A2-restricted hepatitis C virus-specific CD8+ T cell responses is linked to naive-precursor frequency.
Schmidt J; Neumann-Haefelin C; Altay T; Gostick E; Price DA; Lohmann V; Blum HE; Thimme R
J Virol; 2011 May; 85(10):5232-6. PubMed ID: 21367907
[TBL] [Abstract][Full Text] [Related]
8. Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles.
Yutani S; Komatsu N; Shichijo S; Yoshida K; Takedatsu H; Itou M; Kuromatu R; Ide T; Tanaka M; Sata M; Yamada A; Itoh K
Cancer Sci; 2009 Oct; 100(10):1935-42. PubMed ID: 19604246
[TBL] [Abstract][Full Text] [Related]
9. Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response.
Kanduc D; Tessitore L; Lucchese G; Kusalik A; Farber E; Marincola FM
Cancer Immunol Immunother; 2008 Aug; 57(8):1215-23. PubMed ID: 18256830
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the inhibitory and stimulatory effects of Core and NS3 candidate HCV vaccines on the cellular immune response.
Borhani K; Bamdad T; Hashempour A; Salek Farrokhi A; Moayedi J
Am J Clin Exp Immunol; 2023; 12(6):153-163. PubMed ID: 38187363
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C Virus-Specific T Cell Receptor mRNA-Engineered Human T Cells: Impact of Antigen Specificity on Functional Properties.
Balasiddaiah A; Davanian H; Aleman S; Pasetto A; Frelin L; Sällberg M; Lohmann V; Koh S; Bertoletti A; Chen M
J Virol; 2017 May; 91(9):. PubMed ID: 28228595
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive mapping of antigen specific T cell responses in hepatitis C virus infected patients with or without spontaneous viral clearance.
Zhang C; Hua R; Cui Y; Wang S; Yan H; Li D; Zhang Y; Tu Z; Hao P; Chen X; Zhong J; Niu J; Jin X
PLoS One; 2017; 12(2):e0171217. PubMed ID: 28170421
[TBL] [Abstract][Full Text] [Related]
13. Functional differences in hepatitis C virus nonstructural (NS) 3/4A- and 5A-specific T cell responses.
Holmström F; Chen M; Balasiddaiah A; Sällberg M; Ahlén G; Frelin L
Sci Rep; 2016 May; 6():24991. PubMed ID: 27141891
[TBL] [Abstract][Full Text] [Related]
14. Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model.
Tagliamonte M; Petrizzo A; Napolitano M; Luciano A; Arra C; Maiolino P; Izzo F; Tornesello ML; Aurisicchio L; Ciliberto G; Buonaguro FM; Buonaguro L
Cancer Immunol Immunother; 2015 Oct; 64(10):1305-14. PubMed ID: 25944003
[TBL] [Abstract][Full Text] [Related]
15. DCs pulsed with novel HLA-A2-restricted CTL epitopes against hepatitis C virus induced a broadly reactive anti-HCV-specific T lymphocyte response.
Guo Z; Zhang H; Rao H; Jiang D; Cong X; Feng B; Wang J; Wei L; Chen H
PLoS One; 2012; 7(6):e38390. PubMed ID: 22701633
[TBL] [Abstract][Full Text] [Related]
16. Unexpected maintenance of hepatitis C viral diversity following liver transplantation.
Gray RR; Strickland SL; Veras NM; Goodenow MM; Pybus OG; Lemon SM; Fried MW; Nelson DR; Salemi M
J Virol; 2012 Aug; 86(16):8432-9. PubMed ID: 22623804
[TBL] [Abstract][Full Text] [Related]
17. A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33.
Matsueda S; Yamada A; Takao Y; Tamura M; Komatsu N; Yutani S; Ide T; Sata M; Itoh K
Cancer Immunol Immunother; 2007 Sep; 56(9):1359-66. PubMed ID: 17265020
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot".
Bihl FK; Loggi E; Chisholm JV; Hewitt HS; Henry LM; Linde C; Suscovich TJ; Wong JT; Frahm N; Andreone P; Brander C
J Transl Med; 2005 May; 3(1):20. PubMed ID: 15888204
[TBL] [Abstract][Full Text] [Related]
19. Heterologous T cell immunity in severe hepatitis C virus infection.
Urbani S; Amadei B; Fisicaro P; Pilli M; Missale G; Bertoletti A; Ferrari C
J Exp Med; 2005 Mar; 201(5):675-80. PubMed ID: 15753202
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice.
Matsui M; Moriya O; Belladonna ML; Kamiya S; Lemonnier FA; Yoshimoto T; Akatsuka T
J Virol; 2004 Sep; 78(17):9093-104. PubMed ID: 15308705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
